Article
Omics studies: their use in diagnosis and reclassification of SLE and other systemic autoimmune diseases.
Rheumatology (Oxford, England) - 1 Apr 2017
Teruel Maria, Chamberlain Chris, Alarcón-Riquelme Marta E
Abstract excerpt
Omics studies of systemic autoimmune diseases (SADs) in general, and SLE in particular, have delivered isolated information from transcriptome, epigenome, genome, cytokine and metabolome analyses. Such analyses have resulted in the identification of disease susceptibility genes and the description of IFN expression signatures, allowing extensive insight into the mechanisms of disease and the development of new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
